
BBOT Market Capitalization Overview
Market Cap: $258.84M as of Sep 8, 2025
$258.84M
As of Sep 8, 2025, BBOT has a market capitalization of $258.84M. Over the past 30 days, its market cap has decreased by -0.73%, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of BridgeBio Oncology Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BBOT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BBOT helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of BridgeBio Oncology Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BBOT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BBOT helps investors assess the company's size and compare it with competitors for better investment decisions.
BBOT Market Cap & Key Trends
See BridgeBio Oncology Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in BBOT
Order type
Buy in
Order amount
Est. shares
0 shares
BBOT Market Cap History
Date | Market Cap | Change |
---|---|---|
Sep 2, 2025 | $225.22M | -0.73% |
Aug 12, 2025 | $226.87M | — |
BBOT End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $258.84M | — |
FAQs About BridgeBio Oncology Therapeutics Inc (BBOT) Market Cap
As of Sep 8, 2025, the market capitalization of BBOT is $258.84M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, BridgeBio Oncology Therapeutics Inc’s market capitalization has increased by —, changing from – to $258.84M as of Sep 8, 2025.
In the last 3 months, BridgeBio Oncology Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year –, BridgeBio Oncology Therapeutics Inc’s market capitalization increased from – in January to – in December, reflecting a — change.